journal article·2024-07-28Open access

Luteinizing Hormone-Releasing Hormone (LHRH)-Conjugated Cancer Drug Delivery from Magnetite Nanoparticle-Modified Microporous Poly-Di-Methyl-Siloxane (PDMS) Systems for the Targeted Treatment of Triple Negative Breast Cancer Cells

Stanley C. Eluu, John D. Obayemi, Danyuo Yiporo, Ali A. Salifu, Augustine O. Oko, Killian Onwudiwe, Toyin Aina, Josephine C. Oparah, Chukwudi C. Ezeala, Precious O. Etinosa, Sarah A. Osafo, Malachy C. Ugwu, Charles O. Esimone, Winston O. Soboyejo

Abstract

This study presents LHRH conjugated drug delivery via a magnetite nanoparticle-modified microporous Poly-Di-Methyl-Siloxane (PDMS) system for the targeted suppression of triple-negative breast cancer cells. First, the MNP-modified PDMS devices are fabricated before loading with targeted and untargeted cancer drugs. The release kinetics from the devices are then studied before fitting the results to the Korsmeyer–Peppas model. Cell viability and cytotoxicity assessments are then presented using results from the Alamar blue assay. Apoptosis induction is then elucidated using flow cytometry. The in vitro drug release studies demonstrated a sustained and controlled release of unconjugated drugs (Prodigiosin and paclitaxel) and conjugated drugs [LHRH conjugated paclitaxel (PTX+LHRH) and LHRH-conjugated prodigiosin (PG+LHRH)] from the magnetite nanoparticle modified microporous PDMS devices for 30 days at 37 °C, 41 °C, and 44 °C. At 24, 48, 72, and 96 h, the groups loaded with conjugated drugs (PG+LHRH and PTX+LHRH) had a significantly higher (p < 0.05) percentage cell growth inhibition than the groups loaded with unconjugated drugs (PG and PTX). Additionally, throughout the study, the MNP+PDMS (without drug) group exhibited a steady rise in the percentage of cell growth inhibition. The flow cytometry results revealed a high incidence of early and late-stage apoptosis. The implications of the results are discussed for the development of biomedical devices for the localized and targeted release of cancer drugs that can prevent cancer recurrence following tumor resection.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Retinoids in leukemia and cellular processes · Growth Hormone and Insulin-like Growth Factors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Ifite Awka 420110, Nigeria

Department of Biotechnology, Ebonyi State University, Abakaliki 480101, Nigeria

Department of Mechanical and Material Science Engineering, Higgins Lab, Worcester Polytechnic Institute (WPI), 100 Institute Road, Worcester, MA 01609, USA

Department of Biomedical Engineering, Worcester Polytechnic Institute, Gateway Park Life Sciences and Bioengineering Centre, 60 Prescott Street, Worcester, MA 01609, USA

Department of Mechanical Engineering, Ashesi University, Berekuso PMB CT3, Ghana

Department of Mechanical Engineering, Academic City University College, Haatso-Accra P.O. Box AD 421, Ghana

Department of Engineering, Morrissey College of Arts and Science, Boston College, Chestnut Hill, MA 02467, USA

Department of Biology and Biotechnology, David Umahi Federal University of Health Sciences, Uburu 480101, Nigeria

Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA

Department of Biomedical Engineering, Collage of Engineering, Afe Babalola University, KM 8.5 Afe Babalola Way, Ado-Ekiti 360001, Nigeria

Department of Material Science, African University of Science and Technology, Km 10 Airport Road, Abuja 900107, Nigeria

Department of Biotechnology, Worcester State University, Worcester, MA 01602, USA

Department of Material Science and Engineering, University of Ghana, Legon, Accra P.O. Box LG 1181, Ghana

Biomaterial Science Department, Dental School, College of Health Sciences, University of Ghana, Korle bu, Accra P.O. Box KB 52, Ghana

Department of Engineering, SUNY Polytechnic Institute,100 Seymour Rd, Utica, NY 13502, USA

Funding

Pan African Material Institute · Worcester Polytechnic Institute (WPI) · SUNY Polytechnic Institute (SPI)

References (57)

Show source-provided references
1. World Health Organization (2024, March 14). WHO Launches New Roadmap on Breast Cancer. Available online: https://www.who.int/news/item/03-02-2023-who-launches-new-roadmap-on-breast-cancer#:~:text=There%20are%20more%20than%202.3,cause%20of%20female%20cancer%20deaths.
2. Biological subtypes of breast cancer: Prognostic and therapeutic implications10.5306/wjco.v5.i3.412 ↗
3. Molecular and cellular heterogeneity in breast cancer: Challenges for personalized medicine10.1016/j.ajpath.2013.08.002 ↗
4. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies10.1172/JCI45014 ↗
5. Triple-negative breast cancer: Clinical features and patterns of recurrence10.1158/1078-0432.CCR-06-3045 ↗
6. Triple-negative breast cancer molecular subtyping and treatment progress10.1186/s13058-020-01296-5 ↗
7. Laser-induced heating of polydimethylsiloxane-magnetite nanocomposites for hyperthermic inhibition of triple-negative breast cancer cell proliferation10.1002/jbm.b.35124 ↗
8. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance10.1073/pnas.2232479100 ↗
9. Controlled drug delivery vehicles for cancer treatment and their performance10.1038/s41392-017-0004-3 ↗
10. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery10.1038/nrd4333 ↗
11. Drug delivery systems: An updated review10.4103/2230-973X.96920 ↗
12. Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer10.1016/j.pmatsci.2023.101070 ↗
13. Magnetic nanoparticles in cancer therapy and diagnosis10.1002/adhm.201901058 ↗
14. Applications of magnetic nanoparticles in biomedicine: The story so far10.1088/0022-3727/49/50/501002 ↗
15. Magnetic Field Triggerable Macroporous PDMS Sponge Loaded with an Anticancer Drug, 5-Fluorouracil. ACS Biomater
16. Organs-on-chips at the frontiers of drug discovery10.1038/nrd4539 ↗
17. Ma, P., Jiang, L., Luo, X., Chen, J., Wang, Q., Chen, Y., Ye, E., Loh, X.J., Wu, C., and Wu, Y.L. (2022). Hybrid Polydimethylsiloxane (PDMS) Incorporated Thermogelling System for Effective Liver Cancer Treatment. Pharmaceutics, 14.10.3390/pharmaceutics14122623 ↗
18. Direct Intranuclear Anticancer Drug Delivery via Polydimethylsiloxane Nanoparticles: In vitro and in vivo Xenograft Studies10.1021/acsami.7b08806 ↗
19. Bioactive nanotherapeutic trends to combat triple negative breast cancer
20. Targeted chemotherapy for triple-negative breast cancers via LHRH receptor
21. LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer10.1038/s41598-020-64979-1 ↗
22. Sanchez, A.M., Flamini, M.I., Zullino, S., Russo, E., Giannini, A., Mannella, P., Naccarato, A.G., Genazzani, A.R., and Simoncini, T. (2018). Regulatory actions of LH and follicle-stimulating hormone on breast cancer cells and mammary tumors in rats. Front. Endocrinol., 9.10.3389/fendo.2018.00239 ↗
23. Swelling of poly(N-isopropylacrylamide) P(NIPA)-based hydrogels with bacterial-synthesized prodigiosin for localized cancer drug delivery10.1016/j.msec.2015.09.090 ↗
24. Sustained release of alpha-methylacyl-CoA racemase (AMACR) antibody-conjugated and free doxorubicin from silica nanoparticles for prostate cancer cell growth inhibition10.1002/jbm.b.35185 ↗
25. Microsphere design for the colonic delivery of 5-fluorouracil10.1016/S0168-3659(03)00195-0 ↗
26. Magnetite nanoparticle coated with amphiphilic bilayer surfactant of polysiloxane and poly(poly(ethylene glycol) methacrylate)10.1007/s11051-012-0953-y ↗
27. Poly(dimethylsiloxane) and poly[vinyltrimethoxysilane-co-2-(dimethylamino) ethyl methacrylate] based cross-linked organic-inorganic hybrid adsorbent for copper(II) removal from aqueous solutions
28. Johnson, L.M., Gao, L., Shields, W., Smith, M., Efimenko, K., Cushing, K., Genzer, J., and López, G.P. (2013). Elastomeric microparticles for acoustic mediated bioseparations. J. Nanobiotechnol., 11, Available online: http://www.jnanobiotechnology.com/content/11/1/22.10.1186/1477-3155-11-22 ↗
29. Formulation and evaluation of metformin HCl floating microspheres10.3329/ajmbr.v1i3.26445 ↗
30. Preparation and characterization of magnetite-PDMS composites by magnetic induction heating10.1016/j.matchemphys.2015.08.038 ↗
31. Polymeric nanoparticles containing diazepam: Preparation, optimization, characterization, in-vitro drug release and release kinetic study10.1186/s40580-016-0061-2 ↗
32. Jeronimo, K., Koutsos, V., Cheung, R., and Mastropaolo, E. (2021). PDMS-ZnO piezoelectric nanocomposites for pressure sensors. Sensors, 21.10.3390/s21175873 ↗
33. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide10.3109/10837450.2013.819014 ↗
34. Application of Nanomedicine to the CNS Diseases10.1016/bs.irn.2016.06.002 ↗
35. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems10.1517/17425241003602259 ↗
36. Effect of Temperature on Drug Release: Production of 5-FU-Encapsulated Hydroxyapatite-Gelatin Polymer Composites via Spray Drying and Analysis of in vitro Kinetics10.1155/2020/8017035 ↗
37. Effect of temperature-increase rate on drug release characteristics of dextran microspheres prepared by emulsion solvent evaporation process10.1016/j.ijpharm.2006.06.003 ↗
38. Drug release from thin films encapsulated by a temperature-responsive hydrogel10.1039/C8SM02529K ↗
39. In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer10.1038/s41598-023-50656-6 ↗
40. National Center for Biotechnology Information (2024, June 24). PubChem Compound Summary for CID 136183466, Prodigiosin, Available online: https://pubchem.ncbi.nlm.nih.gov/compound/prodigiosin-R1.
41. Drug release study of the chitosan-based nanoparticles10.1016/j.heliyon.2021.e08674 ↗
42. Polymeric conjugates for drug delivery10.1021/cm2031569 ↗
43. Mechanisms of solute release from porous hydrophilic polymers10.1016/0378-5173(83)90064-9 ↗
44. Heredia, N.S., Vizuete, K., Flores-Calero, M., Pazmiño, V.K., Pilaquinga, F., Kumar, B., and Debut, A. (2022). Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid). PLoS ONE, 17.10.1371/journal.pone.0264825 ↗
45. Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., and Shao, A. (2020). Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front. Mol. Biosci., 7.10.3389/fmolb.2020.00193 ↗
46. Apoptosis and cancer drug targeting10.1172/JCI9053 ↗
47. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system10.2147/IJN.S126245 ↗
48. Bai, X., Smith, Z.L., Wang, Y., Butterworth, S., and Tirella, A. (2022). Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review. Micromachines, 13.10.3390/mi13101623 ↗
49. Adepu, S., and Ramakrishna, S. (2021). Controlled drug delivery systems: Current status and future directions. Molecules, 26.10.3390/molecules26195905 ↗
50. Sustained and controlled release of herbal medicines: The concept of synchronized release10.1016/j.ijpharm.2019.01.074 ↗
51. Targeted Drug Delivery—From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives10.2147/JMDH.S313968 ↗
52. Veselov, V.V., Nosyrev, A.E., Jicsinszky, L., Alyautdin, R.N., and Cravotto, G. (2022). Targeted Delivery Methods for Anticancer Drugs. Cancers, 14.10.3390/cancers14030622 ↗
53. Programmed cell death detection methods: A systematic review and a categorical comparison10.1007/s10495-022-01735-y ↗
54. Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells
55. Mechanisms of cancer cell death induction by paclitaxel: An updated review10.1007/s10495-022-01750-z ↗
56. Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action10.2174/1568009033481967 ↗
57. Li, D., Liu, J., Wang, X., Kong, D., Du, W., Li, H., Hse, C.Y., Shupe, T., Zhou, D., and Zhao, K. (2018). Biological potential and mechanism of prodigiosin from Serratia marcescens subsp. Lawsoniana in human choriocarcinoma and prostate cancer cell lines. Int. J. Mol. Sci., 19.10.3390/ijms19113465 ↗